CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 80 enrolled
Drug / intervention
To surgery patients, Tocopherol capsules. +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00678834
NCT00678834Early Ph 1Completed

Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol

Chandan K Sen·interventional·Posted May 16, 2008·Updated Sep 16, 2014

In Brief

A Early Phase 1 clinical trial evaluating To surgery patients, Tocopherol capsules., Tocotrienol to healthy subjects., and 1 other intervention for End Stage Cardiac Failure and 5 related conditions. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Levels of tocotrienol in human tissues following supplementation is not currently known. The objective of this present study is to determine the levels of this form of vitamin E in the human tissues such as skin, heart, lung, liver, adipose tissue, Brain and cerebrospinal fluid (CSF) following oral supplementation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsCarotech Inc.

Timeline

Early Ph 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 16, 2008
Enrollment StartMar 1, 2006
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 18.1 years ago

Interventions

To surgery patients, Tocopherol capsules.dietary

200mg (2 100mg capsules) to take by mouth twice daily to total 400mg daily

Tocotrienol to healthy subjects.dietary

200 mg to take orally two times a day (400 mg a day).

To surgery patients, Tocotrienol capsules.dietary

200mg (2 100mg capsules) to take by mouth twice daily to total 400mg daily